Abstract:Abstract Generalized pustular psoriasis (GPP) is a rare, chronic inflammatory skin condition that is potentially life-threatening. Accumulating evidence suggests that GPP is distinct from the more common plaque psoriasis in terms of aetiology and clinical and dermatological features. The aim of this study was to describe the epidemiology, comorbidities, mortality and healthcare resource use (HCRU) in patients with GPP compared with those with plaque psoriasis in England. A retrospective cohort study of the Clinical Practice Research Datalink (CPRD) Aurum database linked with hospital and mortality data, between 2008 and 2019, was conducted, and HCRU between 2015 and 2019 was calculated. Prevalence rates, comorbidities and survival rates were estimated for GPP and plaque psoriasis. Diagnoses were based on CPRD medical codes and International Classification of Diseases 10th Revision codes (L40.1 for GPP, and L40.0 for plaque psoriasis). In total, 373 patients with GPP (62.5% female) and 224 223 patients with plaque psoriasis (49.4% female) were identified. The mean age (SD) was 55.9 years (18.6) for GPP, and 48.5 years (19.1) for patients with plaque psoriasis. A higher proportion of patients with GPP had at least one comorbidity, compared with plaque psoriasis (76.4% vs. 55.9%, respectively). From 2008 to 2019, the prevalence rates per 100 000 persons ranged from 1.61 to 3.0 for GPP, and from 1771 to 1904 for plaque psoriasis. In total, 78 of the 373 (20.9%) patients with GPP died during the study period, compared with 20 771 of 224 223 (9.3%) patients with plaque psoriasis. Compared with plaque psoriasis, survival rates were lower for patients with GPP, particularly those who were over 55 years old and those with a history of at least one comorbidity. Overall, 297 patients with GPP and 181 925 with plaque psoriasis were included in HCRU analysis. Hospitalizations, outpatient visits and accident and emergency visits were more frequent in patients with GPP compared with plaque psoriasis (78% vs. 47%, 92% vs. 75% and 71% vs. 52%, respectively). Our results support previous findings that GPP is a distinct disease from plaque psoriasis with a different epidemiology. Compared with plaque psoriasis, patients with GPP had higher mortality and were found to have higher disease burden, demonstrating a high unmet need in this patient group. The study was supported and funded by Boehringer Ingelheim. Boehringer Ingelheim was given the opportunity to review the manuscript for medical and scientific accuracy, as well as intellectual property considerations.

Preliminary analysis of blood coagulation and fibrinolysis in generalized pustular psoriasis

The Prevalence and Disease Characteristics of Generalized Pustular Psoriasis

Generalized Pustular Psoriasis and Systemic Organ Dysfunctions

Clinical Characteristics and Outcomes of Generalized Pustular Psoriasis Flares

Detection of serum interleukin-1,-6 and tumor necrosis factor-α in patients with generalized pustular psoriasis

Analysis of peripheral blood parameter in children patients with acute generalized pustular psoriasis

Analysis on metabolic diseases related marks in patients with generalized pustular psoriasis

Diagnosis of Generalized Pustular Psoriasis

Considerations for defining and diagnosing generalized pustular psoriasis

Vascular endothelial damage as well as changes in coagulation and anticoagulation function in psoriatic patients

Changes of vascular endothelial damage and anticoagulation function in patients with arthropathic psoriasis

P073 Prevalence, mortality and healthcare resource use for generalized pustular psoriasis compared with plaque psoriasis in England: a population-based cohort study

Increased neutrophil‐derived IL‐17A identified in generalized pustular psoriasis

Clinical Characteristics and Disease Burden of Patients with Moderate-to-Severe Generalized Pustular Psoriasis Flares in Taiwan

Clinical Disease Measures in Generalized Pustular Psoriasis

Platelet-associated Parameters in Patients with Psoriasis: A PRISMA-compliant Systematic Review and Meta-Analysis.

Understanding the Pathogenesis of Generalized Pustular Psoriasis Based on Molecular Genetics and Immunopathology

Characterization of Generalized Pustular Psoriasis in Northwest China: A Single-Center Retrospective Study

The Clinical Analysis of 44 Cases of Generalized Pustular Psoriasis

Clinical Course and Characteristics of Generalized Pustular Psoriasis

Generalized Pustular Psoriasis: A Review on Clinical Characteristics, Diagnosis, and Treatment